D-1528-2016 Class III Terminated
FDA drug recall D-1528-2016 was initiated by Pfizer Inc. on Sep 15, 2016 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Lot and/or Exp Date: Bottles were incorrectly labeled with an expiry date of 11/17; the correct date is 09/17. The recall status is terminated (terminated Aug 9, 2017). Affected quantity: 1,316 bottles (1,316,000 tablets).
Recall details
- Product Type
- Drugs
- Report Date
- Oct 5, 2016
- Initiation Date
- Sep 15, 2016
- Termination Date
- Aug 9, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,316 bottles (1,316,000 tablets)
Product description
PREMARIN (conjugated estrogen tablets, USP) 1.25 mg, 1000- count bottle, Rx only, Distributed by: Wyeth Pharmaceuticals Inc. A subsidiary of Pfizer Inc. Philadelphia, PA 19101, NDC 0046-1104-91
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp Date: Bottles were incorrectly labeled with an expiry date of 11/17; the correct date is 09/17.
Distribution pattern
Nationwide
Code information
Lot # M35953S; Exp. 11/17 (labeled).
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1528-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026